Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological standardization of Lolium perenne allergenic extract in histamine equivalent prick units
2010-023949-29Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Nov 2011
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lolium perenne allergenic extract in grass pollen allergy and Allergy to Perennial Ryegrass (LpA), sponsored by LETI Pharma. Started Nov 2011; status: completed.
02
Drugs
lolium perenne allergenic extract
03
Conditions
grass pollen allergyAllergy to Perennial Ryegrass (LpA)
Beyond the preview
Go deeper on 2010-023949-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023949-29.